Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
Authors:
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (5) , 1055-1063
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort studyBMC Pulmonary Medicine, 2012
- Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEALChest, 2010
- Pulmonary Arterial HypertensionChest, 2010
- A USA-based registry for pulmonary arterial hypertension: 1982–2006European Respiratory Journal, 2007
- Clinical differences between idiopathic and scleroderma‐related pulmonary hypertensionArthritis & Rheumatism, 2006
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 2003
- Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*Chest, 2003
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Primary pulmonary hypertensionThe Lancet, 1998
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993